Committee for Advanced Therapies (CAT): 7–9 October 2026

The Committee for Advanced Therapies meets at the European Medicines Agency in Amsterdam from 7 to 9 October 2026. CAT holds the scientific assessment of quality, safety and efficacy for advanced therapy medicinal products, and prepares the opinions that the Committee for Medicinal Products for Human Use subsequently adopts.

EMA publishes the agenda ahead of each meeting and the minutes afterwards on the CAT meeting reports page. For developers moving an ATMP through the EU regulatory pathway, those documents show which products the committee took up and what it concluded.